Medical News

RSS

Baxter to commence second GAMMAGARD LIQUID Phase III trial in Alzheimer's

Baxter International Inc. today provided an update on its clinical program evaluating the use of its GAMMAGARD LIQUID 10%, for the treatment of mild to moderate Alzheimer's disease.

From Baxter International Inc. 24 Jan 2012

Phenomenex, AB SCIEX collaborate to improve food testing

AB SCIEX, a global leader in life science analytical technologies, and Phenomenex, a global leader in separation science techniques, today announced a collaboration agreement designed to significantly improve food testing.

24 Jan 2012

Possible link between vascular lesions and Alzheimer's disease

Approximately 20 percent of all stroke survivors will develop cognitive problems later in life, including vascular dementia. Experts with the Methodist Neurological Institute in Houston say recent research showing a possible link between vascular lesions and Alzheimer's disease is yet another reason to be more vigilant in our efforts to prevent a stroke.

24 Jan 2012

Takeda receives FDA approval for VELCADE sNDA to treat MM

Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for VELCADE(bortezomib), which updates the label to include the subcutaneous method of administration in all approved indications: multiple myeloma and mantle cell lymphoma after at least one prior therapy.

24 Jan 2012

Elderly patients more likely to develop respiratory or gastrointestinal infections after ED visits

Elderly patients who have visited an emergency department (ED) are three times more likely to develop respiratory or gastrointestinal infections in the week following their return to a long-term care facility, such as a Centre d'H-bergement de Soins de Longue Dur-e.

24 Jan 2012

State news: Rate hikes approved in Mass., Va. families still wait for autism coverage, health IT booming

State regulators have approved premium increases averaging 2.3 percent for health insurance covering hundreds of thousands of residents, the most modest hikes in at least a decade and a sign that years of efforts to control costs may be working. The new rates are in Massachusetts' "small group'' market, which includes tens of thousands of small businesses as well as self-employed and formerly uninsured individuals.

24 Jan 2012

PLC Systems initiates enrollment in RenalGuard pivotal trial for CIN

PLC Systems Inc., a company focused on innovative medical device technologies, announced the successful enrollment of the first patient in the CIN-RG trial, the company's pivotal trial to study the efficacy of its RenalGuard Therapy and RenalGuard System in the prevention of Contrast-Induced Nephropathy.

24 Jan 2012

Researchers uncover 13 novel genetic loci linked with onset of menopause

An international team of researchers from the Boston University Schools of Public Health and Medicine and other institutions has uncovered 13 genetic loci, linked to immune function and DNA repair, that are factors in the age of onset of menopause.

24 Jan 2012

Pets help women manage HIV/AIDS: Study

A spoonful of medicine goes down a lot easier if there is a dog or cat around. Having pets is helpful for women living with HIV/AIDS and managing their chronic illness, according to a new study from the Frances Payne Bolton School of Nursing at Case Western Reserve University.

24 Jan 2012

Novel method can rapidly scan and capture 3D maps of muscle structure

Simon Fraser University associate professor James Wakeling is adding to the arsenal of increasingly sophisticated medical imaging tools with a new signal-processing method for viewing muscle activation details that have never been seen before.

23 Jan 2012

Study explores global rise of monogamous marriage as a dominant cultural institution

In cultures that permit men to take multiple wives, the intra-sexual competition that occurs causes greater levels of crime, violence, poverty and gender inequality than in societies that institutionalize and practice monogamous marriage.

23 Jan 2012

UCSF-led study to sequence DNA from 4,000 people with epilepsy

To probe the genetic secrets of one of the most common neurological diseases, more than 4,000 people with various forms of epilepsy will have their DNA decoded over the next five years in a study led by researchers at the University of California, San Francisco (UCSF) and several collaborating institutions.

23 Jan 2012

Ikaria receives FDA orphan drug designation for use of iNO in PAH

Ikaria, Inc., a critical care company focused on developing and commercializing innovative therapies for critically ill patients, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the use of inhaled nitric oxide (iNO) with the INOpulse DS drug-delivery system as a combination product for pulmonary arterial hypertension.

23 Jan 2012

Study explains how bacterial biofilms expand to form slimy mats on teeth, surgical instruments

New research at Harvard explains how bacterial biofilms expand to form slimy mats on teeth, pipes, surgical instruments, and crops.

23 Jan 2012

3 of 4 Americans live in states still flummoxed by how to deliver the health law's promise of affordable care

News outlets report on a variety of health law implementation issues, including an Associated Press report detailing how the overhaul is lagging in the states. Other reports examine questions about ACOs, essential benefits and other specific provisions.

23 Jan 2012

Lab21 acquires new real time PCR technology

Lab21 Limited, the global specialist in personalized medicine and clinical diagnostics, today announces the completion of a worldwide license from Cooperative Diagnostics to use its suite of patents and expertise for the development of its growing pipeline of molecular diagnostic kits. Financial details of the agreement were not disclosed.

23 Jan 2012

Guided Therapeutics seeks CE Mark approval for LuViva Advanced Cervical Scan

Guided Therapeutics, Inc. today announced that it has submitted the application for CE Mark approval for LuViva Advanced Cervical Scan. The CE Mark is required to market LuViva in the 27 nations that comprise the European Union (EU).

23 Jan 2012

Cooperation needed to fight TB

In this post in Global Health Frontline News' "Notes From the Field" blog, Kevin Cain, chief of the tuberculosis (TB) branch for a research and public health collaboration between the Kenya Medical Research Institute (KEMRI) and the CDC in Kisumu, Kenya, reports on TB research underway as part of the collaboration.

23 Jan 2012

ClearCollar cervical collar receives Premier Technology Breakthroughs award

The Premier healthcare alliance today announced that Clear Advantage Collar of Charlotte, N.C. has been awarded a Premier Technology Breakthroughs award for its ClearCollar cervical collar.

23 Jan 2012

Patient enrollment complete in Enlivex Phase I/II clinical trial for autoimmune diseases

Hadasit Bio-Holdings a publicly traded portfolio of biotech companies, all based on intellectual property developed and owned by Hadassah University Hospital, Israel's foremost medical research center, today announced that the recruitment of 13 patients for the Enlivex Phase I/II clinical trial has been completed.

23 Jan 2012